Purpose

The goal of this clinical trial is to learn if the Talk With Me Baby (TWMB) program improves the home-language environment for at-risk families with children ages two to six months when primary care providers deliver the program during well-child checkups. The main question it aims to answer is: Will the TWMB program increase the time a caregiver talks to their infant? Participants will: 1. Come to at least four well-child checkups 2. Receive the TWMB program from the provider during the checkups 3. Record their conversations with their infant before they receive the program and after they receive the program four times.

Conditions

Eligibility

Eligible Ages
Between 2 Months and 6 Months
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

For this study, each child-caregiver dyad will consist of: 1. A caregiver who will receive TWMB during routine well-childcare checkups (WCC) visits for their child at participating clinics and 2. The child of the above caregiver for whom the WCC visits are conducted. A potential caregiver participant must meet all the following inclusion criteria to enroll in the study: 1. Be the age of majority or older, as defined by the state of residency. 2. Able to complete study measures in English. 3. Have the legal authority to consent to participate for themselves and to consent on behalf of their child. To proceed to the follow-up portion of the study, the caregiver (dyad) must have a LENA baseline assessment score that is ≤ 75th percentile compared to a child's age-referenced normative data. A potential child participant must meet all the following inclusion criteria to be enrolled in the study: 1. Receive WCC at a participating clinic from a participating provider. 2. Be two to six months (+ 0-30 days) old at enrollment. 3. Was born at full term (> 37 weeks gestation). 4. Was born in a singleton birth (i.e., was the only child delivered during the birth).

Exclusion Criteria

A potential caregiver participant must not meet any of the following exclusion criteria to enroll in the study: 1. Has a cognitive impairment or a visual or hearing impairment known to the clinic that limits their ability to make decisions about participating or engaging with the assessments, based on the site primary investigator's (PI's) assessment and local human subjects' research policies. 2. Does not live with child or spend at least two full days (i.e., at least 48 hours) per week with the child. 3. Does not plan for the child to continue receiving services at the participating clinic for at least 12 months. A potential child participant must not meet any of the following exclusion criteria to enroll in the study: 1. Significant developmental delay or cognitive, visual, or hearing impairment known to the clinic. 2. Previously attended WCC visit prior to enrollment that occurred during the TWMB trial.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Prevention
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Talk With Me Baby
  • Behavioral: Talk with Me Baby
    Primary care providers will embed Talk With Me Baby (TWMB) within standard-of-care Well-Child Care visits for children ≤36 months of age. Children will receive usual care plus a brief language-promotion intervention (TWMB) in up to 4 consecutive Well-Child Care visits during their 12-month period.

Recruiting Locations

Kansas University Medical Center
Kansas City, Kansas 66160
Contact:
Brenda Salley, PhD
913-945-7944
bsalley@kumc.edu

More Details

Status
Recruiting
Sponsor
IDeA States Pediatric Clinical Trials Network

Study Contact

Song Ounpraseuth, PhD
501-686-7233
STOunpraseuth@uams.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.